The all-cash deal has involved Novo Holdings acquiring Catalent for $16.5bn, including debt. It will then sell three of ...

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

FedEx, the shipping and logistics giant, plans to spin off its freight trucking business, Novo Nordisk sinks after ...

The FDA removed Eli Lilly’s LLY tirzepatide injection products from the drug shortage list after determining that Lilly’s ...

The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' next-generation treatment for a rare and ...

Eli Lilly has called on financial regulators to look into the antitrust implications of Novo Holdings' purchase of Catalent and the sale of three manufacturing facilities to Novo Nordisk.

Versant Ventures led the Series A, with founding investor Novo Holdings also taking part and joined by SR One, Dawn Biopharma, Pictet, Longview Ventures, and the Export and Investment Fund of Denmark.

During the third quarter, the Lazard International Equity Advantage Portfolio underperformed the MSCI EAFE Index (net). Click ...

Lilly to offer single-dose vials of weight-loss drug on telehealth platform Ro Healthcare & Pharmaceuticalscategory· December 11, 2024 Novo Holdings on Friday gained unconditional EU antitrust ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...